Monashee Investment Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-505,000
Closed -$5.95M 58
2022
Q4
$5.95M Buy
+505,000
New +$5.77M 2.56% 13
2022
Q3
Sell
-37,500
Closed -$371K 56
2022
Q2
$371K Buy
+37,500
New +$757K 0.14% 25

Other funds holding ASPN

Monashee Investment Management's ASPN Position: Q1 2023 in Review

Monashee Investment Management sold out of Aspen Aerogels (ASPN) in Q1 2023, closing a stake of 505,000 shares — an estimated $5.95M sold.

Monashee Investment Management first reported a position in ASPN in Q2 2022 and held it in 2 quarters. The position peaked at $5.95M in Q4 2022. 156 funds tracked by Wall St. Rank hold ASPN as of Q1 2023.

  • Monashee Investment Management reported no remaining Aspen Aerogels position as of Q1 2023 after selling out during the quarter.
  • Monashee Investment Management sold 505,000 Aspen Aerogels shares in Q1 2023, an estimated $5.95M.
  • Monashee Investment Management first reported a position in Aspen Aerogels in Q2 2022 and held it in 2 quarters.
  • Monashee Investment Management's Aspen Aerogels position peaked at $5.95M in Q4 2022.
  • 156 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2023.

Based on Monashee Investment Management's 13F filing for Q1 2023, filed 5 May 2023.